1. Home
  2. MLYS vs HNRG Comparison

MLYS vs HNRG Comparison

Compare MLYS & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • HNRG
  • Stock Information
  • Founded
  • MLYS 2019
  • HNRG 1949
  • Country
  • MLYS United States
  • HNRG United States
  • Employees
  • MLYS N/A
  • HNRG N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • HNRG Coal Mining
  • Sector
  • MLYS Health Care
  • HNRG Energy
  • Exchange
  • MLYS Nasdaq
  • HNRG Nasdaq
  • Market Cap
  • MLYS 634.6M
  • HNRG 551.9M
  • IPO Year
  • MLYS 2023
  • HNRG N/A
  • Fundamental
  • Price
  • MLYS $9.77
  • HNRG $12.79
  • Analyst Decision
  • MLYS Strong Buy
  • HNRG Strong Buy
  • Analyst Count
  • MLYS 2
  • HNRG 2
  • Target Price
  • MLYS $30.00
  • HNRG $15.00
  • AVG Volume (30 Days)
  • MLYS 266.6K
  • HNRG 382.2K
  • Earning Date
  • MLYS 11-11-2024
  • HNRG 03-12-2025
  • Dividend Yield
  • MLYS N/A
  • HNRG N/A
  • EPS Growth
  • MLYS N/A
  • HNRG N/A
  • EPS
  • MLYS N/A
  • HNRG N/A
  • Revenue
  • MLYS N/A
  • HNRG $429,359,000.00
  • Revenue This Year
  • MLYS N/A
  • HNRG N/A
  • Revenue Next Year
  • MLYS N/A
  • HNRG $7.22
  • P/E Ratio
  • MLYS N/A
  • HNRG N/A
  • Revenue Growth
  • MLYS N/A
  • HNRG N/A
  • 52 Week Low
  • MLYS $8.58
  • HNRG $4.33
  • 52 Week High
  • MLYS $16.91
  • HNRG $14.00
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 37.52
  • HNRG 62.82
  • Support Level
  • MLYS $9.18
  • HNRG $12.26
  • Resistance Level
  • MLYS $9.97
  • HNRG $12.85
  • Average True Range (ATR)
  • MLYS 0.85
  • HNRG 0.64
  • MACD
  • MLYS -0.25
  • HNRG 0.13
  • Stochastic Oscillator
  • MLYS 24.53
  • HNRG 85.25

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About HNRG Hallador Energy Company

Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.

Share on Social Networks: